GTCR, a private equity firm, announces that its management partnership with Gregory T. Lucier, Corza Health, has simultaneously acquired and merged Surgical Specialties Corporation (Surgical Specialties) and the TachoSil Fibrin Sealant Patch (TachoSil) to create a new company, Corza Medical. Surgical Specialties is a medical technology company focused on high-performance surgical sutures and ophthalmic knives. TachoSil, previously owned by Takeda Pharmaceutical Company Limited, is a differentiated surgical patch product line used to enable safe and fast bleeding control during surgeries.

The company will be led by Executive Chairman Gregory T. Lucier and CEO Dan Croteau, with a global team of over 1,700 employees supporting clinicians, distributors, and medical device companies. Corza Medical will provide healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Sharpoint ophthalmic knives, and the TachoSil fibrin sealant patch.

“The formation of Corza Medical immediately creates a market-leading, surgical technology business that brings together brands with decades of trust and clinical relevance,” says Lucier. “Our platform of technologies and our commitment to providing exceptional service will help transform surgical outcomes and change the lives of patients around the globe, while providing a foundation for continued, long-term growth.”

In 2019, GTCR partnered with Lucier to create Corza Health. The carve-out of TachoSil and its merger with Surgical Specialties together represent the platform acquisition for the partnership.

“Corza Medical will be laser-focused on bringing differentiated, high-performance technologies to market with world-class service and value,” adds Croteau. “We are excited to further build out the Corza Medical portfolio with acquisitions of complementary businesses and technologies, and to become an acquirer of choice in this fragmented market. I look forward to working alongside the GTCR team and Greg on this growth journey.”

The company will be headquartered in Westwood, Mass., and operate in 13 countries throughout North America, Europe, and Asia, with manufacturing facilities in the United States, Mexico, England, Germany, and China.